Human GYPA/CD235a/GPA ORF/cDNA clone-Lentivirus particle (NM_001308190)
Cat. No.: vGMLP003338
Pre-made Human GYPA/CD235a/GPA Lentiviral expression plasmid for GYPA lentivirus packaging, GYPA lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
GYPA/CD235a products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP003338 | Human GYPA Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP003338 |
Gene Name | GYPA |
Accession Number | NM_001308190 |
Gene ID | 2993 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 354 bp |
Gene Alias | CD235a,GPA,GPErik,GPSAT,HGpMiV,HGpMiXI,HGpSta(C),MN,MNS,PAS-2 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGTATGGAAAAATAATCTTTGTATTACTATTGTCAGATACGCACAAACGGGACACATATGCAGCCACTCCTAGAGCTCATGAAGTTTCAGAAATTTCTGTTAGAACTGTTTACCCTCCAGAAGAGGAAACCGGAGAAAGGGTACAACTTGCCCATCATTTCTCTGAACCAGAGATAACACTCATTATTTTTGGGGTGATGGCTGGTGTTATTGGAACGATCCTCTTAATTTCTTACGGTATTCGCCGACTGATAAAGAAAAGCCCATCTGATGTAAAACCTCTCCCCTCACCTGACACAGACGTGCCTTTAAGTTCTGTTGAAATAGAAAATCCAGAGACAAGTGATCAATGA |
ORF Protein Sequence | MYGKIIFVLLLSDTHKRDTYAATPRAHEVSEISVRTVYPPEEETGERVQLAHHFSEPEITLIIFGVMAGVIGTILLISYGIRRLIKKSPSDVKPLPSPDTDVPLSSVEIENPETSDQ |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-MP0565-Ab | Anti-GLPA/ GYPA/ CD235a monoclonal antibody |
Target Antigen | GM-Tg-g-MP0565-Ag | GYPA VLP (virus-like particle) |
ORF Viral Vector | pGMLP003338 | Human GYPA Lentivirus plasmid |
ORF Viral Vector | vGMLP003338 | Human GYPA Lentivirus particle |
Target information
Target ID | GM-MP0565 |
Target Name | GYPA |
Gene ID | 2993, 574101, 688972, 109498956, 617836, 102150508 |
Gene Symbol and Synonyms | CD235a,GPA,GPErik,GPSAT,GYPA,HGpMiV,HGpMiXI,HGpSta(C),MN,MNS,PAS-2 |
Uniprot Accession | P02724 |
Uniprot Entry Name | GLPA_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Not Available |
Disease | Not Available |
Gene Ensembl | ENSG00000170180 |
Target Classification | Not Available |
Glycophorins A (GYPA) and B (GYPB) are major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the MN and Ss blood groups. In addition to the M or N and S or s antigens that commonly occur in all populations, about 40 related variant phenotypes have been identified. These variants include all the variants of the Miltenberger complex and several isoforms of Sta, as well as Dantu, Sat, He, Mg, and deletion variants Ena, S-s-U- and Mk. Most of the variants are the result of gene recombinations between GYPA and GYPB. [provided by RefSeq, Jul 2008]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.